This Week we Cover: Another common cold virus? Modeling SARS-CoV-2’s progress through the ages. Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19? New study: Without right messaging, masks… Read More ›
My favorite research this week was on Mesenchymal stem cells treatments for COVID patients. The CDC issued warnings in reference to polysorbate or polyethylene glycol allergy and mRNA vaccines. Plus DATA tracking mRNA vaccines and Hospitalizations. PLUS MORE DATA DATA… Read More ›
Annal of Internal Medicine “Mask Benefit Claims Inconclusive”, Lund University Lockdown Models Heavily Flawed” Plus new Data Vaccine to Population Ratio This week we review the above plus start mining data in reference to COVID-19 Vaccine rate and Hospital Occupancy… Read More ›
1. We review now the very strong hypothesis that Sars-COV-2 is now aerosolized on a sub-micron level greatly reducing any impact PPE may have and greatly increasing transmission vectors. 2. Immunity to COVID-19 appears to last at least 8 months with significant B cell memory. 3. Plus deep dive into global Data that really shows there is no real clear pandemic mitigation strategy that is having any real-world effect except unnecessarily causing hardship among the subject populace.
This week we look at one of the worst cases of media bias to date in reference to the study: Effects of mask-wearing on the inhalability and deposition of airborne SARS-CoV-2 aerosols in human upper airway. Cadmiun and heightened mortality,… Read More ›
This week we run the data analytics on Face Coverings and Country Stats using Seaborn and Pandas as well as cover the DANMASK-19 randomized trial, The Daily Mails fight with the British Government attempt to terrorize it, citizens, with bad… Read More ›